Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- ACCJ Calls For Improvement in Review of Medical Devices
January 9, 2006
- ＜New Year's Greeting＞PhRMA to Work to More Quickly Bring Innovative Drugs to Patients
January 9, 2006
- MEDICAL DEVICE NEWS IN BRIEF
January 9, 2006
- Surprise Free Forecasts For 2006
January 9, 2006
- General Account Budget Totaling \79,686 Bil. Proposed by MOF
January 9, 2006
- Concerns Expressed by Various Parties on Proposed NHI Pricing Reform -1-
January 9, 2006
- Concerns Expressed by Various Parties on Proposed NHI Pricing Reform -2-
January 9, 2006
- Society Working to Have MTX Approved for JIA
January 9, 2006
- Seminar on Drugs for Children: SJP
January 9, 2006
- REGULATORY NEWS IN BRIEF
January 9, 2006
- SymBio Decides on Its First Development Product
January 9, 2006
- BUSINESS NEWS IN BRIEF
January 9, 2006
- NEW PRODUCTS
December 26, 2005
- Both Patients and Medical Professionals Need Education about Mammography: JSBH Seminar
December 26, 2005
- (Proposed) Outline of the FY2006 NHI Pricing System Reform
December 26, 2005
- Company Financial Support Encourages Mammography Screening: J&J
December 26, 2005
- Stop the press!
December 26, 2005
- SURVEY 3 articles
December 26, 2005
- Discussions to Continue on Pricing of Long-listed Drugs, Frequency of Price Revisions
December 26, 2005
- R&D NEWS IN BRIEF
December 26, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…